PHARMAC to widen access to the exceptional circumstances process

Thursday, 21 November 2019

Patients taking lamotrigine who have concerns about the change can talk to their doctor about remaining on the current brand as PHARMAC has widened the criteria for lamotrigine exceptional circumstances.

Read More...

PHARMAC Decision welcomed by Epilepsy New Zealand

Thursday, 21 November 2019

Epilepsy New Zealand President Dr Peter Bergin welcomes the news that Pharmac are now allowing people who have been stable on their previous brands of lamotrigine to continue taking their original brand.

Read More...

PHARMAC wiaves fees to visit doctor.

Thursday, 21 November 2019

If you have visited your doctor recently to seek advice on the brand changes for lamotrigine, your GP can waive the co-payment you would normally pay.

Read More...

SAYR Ventilation Systems - Supporting ENZ

Wednesday, 2 October 2019

SAYR is a ventilation company that helps you create a healthy home. They offer heating, insulation, ventilation, and LED lighting. Get a discount and support Epilepsy New Zealand -- use promotional code EPNZ100.

Read More...

Tell us your experience of changing from Lamictal to Logem

Wednesday, 2 October 2019

From 01 Oct 2019, Pharmac only funds the generic brand of Lamotrigine, called Logem. They no longer fund the Lamictal and Arrow brands. Tell us how it's going for you.

Read More...

BPAC issues new guidelines for Lamotrigine

Thursday, 26 September 2019

BPAC issues new guidelines for Lamotrigine.

Read More...

Petition against Pharmac's drug changes

Thursday, 29 August 2019

A petition is underway calling on Pharmac to reverse its decision on Lamotrigine.

Read More...

Epilepsy NZ Position Statement - Lamotrigine

Wednesday, 28 August 2019

We opposed this change from Lamictal to Logem from the start, and staff have advocated on behalf of people with epilepsy in discussions with Pharmac.

Read More...

Ministry of Health survey improves understanding of epilepsy

Tuesday, 26 March 2019

The Ministry of Health recognises the challenges that people living with epilepsy face and is working to understand the condition better. To help raise awareness of epilepsy and mark Epilepsy New Zealand’s ‘Purple Day’ campaign, the Ministry of Health is releasing the findings of its first Epilepsy Consumer Experience Survey today.

Read More...

Crip the Lit launches "little book with big ideas"

Wednesday, 13 March 2019

Robyn Hunt advises us that one of the right writers featured within this book writes frankly about her epilepsy in a very positive and empowered way.

Read More...

Epilepsy New Zealand partners with innovative Dunedin Company

Thursday, 31 January 2019

Epilepsy New Zealand partners with innovative Dunedin Company Innovative Dunedin Company First Aid Pod, whose pop-up shelters offer privacy during medical emergencies, is linking with Epilepsy New Zealand. First Aid Pods have been selling fast in New Zealand and Australia since being launched in April 2017 by Dunedin based businessmen Tony Watts, Craig Latimer and Braedan Trompetter.

Read More...

Newsletter December 2018

Tuesday, 11 December 2018

Mikayla's Journey

Thursday, 29 November 2018

The story is about our daughter Mikayla who suffers with nocturnal frontal lobe epilepsy.

Read More...

SIR BILL ENGLISH APPOINTED AS PATRON OF EPILEPSY NEW ZEALAND

Thursday, 29 November 2018

Epilepsy New Zealand is proud to announce that Sir Bill English has graciously agreed to become patron of the national organisation. Chair of Epilepsy New Zealand, Dr Peter Bergin says: “We are grateful to welcome Sir Bill English as our patron. To have such a skilled person supporting our cause - which is to improve the quality of life of people and their families living with epilepsy - is invaluable.”

Read More...

Taking medicines for epilepsy, mood, or pain ACC Link

Monday, 5 March 2018

Foetal Anticonvulsant Syndrome ACC has worked with experts from across the sector to let women, their families and their health providers know about the effects of taking antiepileptic medicine during pregnancy. This includes: The use - for epilepsy, mood disorders, and pain management The risk of harm - malformations and cognitive impairments What to do if they're pregnant or planning a pregnancy.

Read More...

Introducing Ashleigh

Monday, 19 February 2018

Ashleigh is a great young woman from Canterbury, this story is written about her epilepsy by her mother, she is heading to Cleveland for epilepsy treatment.

Read More...

Don't Give Up by Adele Hauwai

Monday, 4 December 2017

Adele Hauwai has shared her Living With Epilepsy story as part of the Epilepsy NZ Tell Us About It Competition. People were asked to send in their stories about epilepsy, the challenges they faced and the lessons they have learned that they would like to share with the world.

Read More...

New ILAE Seizure Classification

Friday, 10 March 2017

The ILAE announces the publication in Epilepsia of two new landmark classification documents, one of seizure types and one of the epilepsies.

Read More...

Media Kit

Thursday, 2 February 2017

Media Information Kit

Read More...

View Archived Items

Latest Updates

  • PHARMAC to widen access to the exceptional circumstances process
    21 November 2019

    Patients taking lamotrigine who have concerns about the change can talk to their doctor about remaining on the current brand as PHARMAC has widened the criteria for lamotrigine exceptional circumstances.

  • PHARMAC Decision welcomed by Epilepsy New Zealand
    21 November 2019

    Epilepsy New Zealand President Dr Peter Bergin welcomes the news that Pharmac are now allowing people who have been stable on their previous brands of lamotrigine to continue taking their original brand.

  • PHARMAC wiaves fees to visit doctor.
    21 November 2019

    If you have visited your doctor recently to seek advice on the brand changes for lamotrigine, your GP can waive the co-payment you would normally pay.

  • Tell us your experience of changing from Lamictal to Logem
    2 October 2019

    From 01 Oct 2019, Pharmac only funds the generic brand of Lamotrigine, called Logem. They no longer fund the Lamictal and Arrow brands. Tell us how it's going for you.

  • BPAC issues new guidelines for Lamotrigine
    26 September 2019

    BPAC issues new guidelines for Lamotrigine.

  • Petition against Pharmac's drug changes
    29 August 2019

    A petition is underway calling on Pharmac to reverse its decision on Lamotrigine.

  • Epilepsy NZ Position Statement - Lamotrigine
    28 August 2019

    We opposed this change from Lamictal to Logem from the start, and staff have advocated on behalf of people with epilepsy in discussions with Pharmac.

  • Introducing Ashleigh
    19 February 2018

    Ashleigh is a great young woman from Canterbury, this story is written about her epilepsy by her mother, she is heading to Cleveland for epilepsy treatment.

  • Don't Give Up by Adele Hauwai
    4 December 2017

    Adele Hauwai has shared her Living With Epilepsy story as part of the Epilepsy NZ Tell Us About It Competition. People were asked to send in their stories about epilepsy, the challenges they faced and the lessons they have learned that they would like to share with the world.

  • New ILAE Seizure Classification
    10 March 2017

    The ILAE announces the publication in Epilepsia of two new landmark classification documents, one of seizure types and one of the epilepsies.

Show Your Support

Shop Online

Epilepsy NZ has an online shop!

Or

Donate Today